Visible and near-infrared spectral changes in the thumb of patients with chronic fatigue syndrome.
Sakudo, Akikazu, Kato, Yukiko Hakariya, Tajima, Seiki et al. · Clinica chimica acta; international journal of clinical chemistry · 2009 · DOI
Quick Summary
Researchers used a special light-based scanning tool to examine the thumbs of ME/CFS patients and healthy people, looking for differences in blood and oxygen levels. They found that ME/CFS patients had higher oxygen-carrying proteins in their blood, less water in their tissues, and signs of faster energy use in their cells. These findings suggest that ME/CFS patients' bodies may be working harder than usual, even at rest.
Why It Matters
This study provides potential objective biomarkers—measurable physical changes—that could help validate ME/CFS as a physiological condition rather than purely psychological. If confirmed, these spectroscopic markers might eventually assist in diagnosis and help researchers understand why ME/CFS patients experience fatigue despite apparent metabolic hyperactivity.
Observed Findings
Statistically significant increase in oxyhemoglobin levels in ME/CFS patients' thumbs compared to controls
Statistically significant decrease in water content in thumb tissue of ME/CFS patients
Statistically significant increase in oxidized heme a+a3 and copper in cytochrome c oxidase in CFS patients
Sharp spectral peaks detected at 694, 970, and 1060 nm, with broad peaks at 740-760 and 830-850 nm in both groups
Inferred Conclusions
Accelerated blood flow occurs in the thumbs of ME/CFS patients
Cellular energy metabolism is heightened in thumb tissue of ME/CFS patients
Vis-NIR spectroscopy may reveal measurable physiological differences between ME/CFS patients and healthy controls
Remaining Questions
Do these spectroscopic changes in the thumb reflect systemic metabolic abnormalities throughout the body, or are they localized to peripheral tissues?
What is the functional significance of increased oxyhemoglobin and altered cytochrome c oxidase oxidation state—do they cause or result from ME/CFS pathophysiology?
Can these spectroscopic markers reliably distinguish ME/CFS patients from other fatigue-related conditions, and are they useful for clinical diagnosis?
What This Study Does Not Prove
This study does not prove that elevated oxyhemoglobin or altered cytochrome c oxidase causes ME/CFS fatigue, only that associations exist. It does not establish whether these thumb changes reflect whole-body metabolism or are localized phenomena. The findings are correlational and do not explain the clinical mechanism behind fatigue, nor do they determine whether these changes are primary disease features or secondary consequences.